Status:
WITHDRAWN
Fluids Administration During Combined Clonidine-Arginine Growth Hormone Stimulation Test
Lead Sponsor:
Rabin Medical Center
Conditions:
Growth Hormone Deficiency
Eligibility:
All Genders
7-16 years
Phase:
NA
Brief Summary
The diagnosis of Growth Hormone deficiency in childhood requires the performance of an artificial pharmacological stimulation tests. There are number of substances that increase the secretion of growt...
Eligibility Criteria
Inclusion
- Children referred to combined Arginine- Conidine Growth Hormone stimulation test
- Girls: 7-14 years old and Boys: 7-16 years old
- Weight\>20 kg
- Normal thyroid function
Exclusion
- BMI over percentile 85
- Genetic syndromes or chromosomal disorders
- Steroid treatment
- Renal failure
- Heart failure
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04465565
Start Date
December 1 2020
End Date
August 1 2022
Last Update
February 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schneider Children's Medical Center of Israel
Petah Tikva, Israel, 4920235